A multi-talented secreted protein.
A multi-talented secreted protein.
复制标题
一种多才多艺的分泌蛋白。
DOI:
10.1016/s0166-2236(00)01936-6
复制
发表时间:
2001
影响因子:
15.9
通讯作者:
Mattson,MP
中科院分区:
文献类型:
--
作者:
Mattson,MP
What secreted protein plays a role in learning and memory, promotes neuronal survival and neurite outgrowth, stimulates cell proliferation, modulates microglial reactivity, and can regulate blood coagulation and lipoprotein metabolism? As a hint, it is derived from an axonally transported integral membrane protein that plays a central role in the pathogenesis of Alzheimer’s disease. This multi-talented protein is the secreted form of β-amyloid precursor protein (sAPP). The history of research on such secreted proteins is that they are initially discovered in one tissue and are subsequently shown to have a broad sphere of influence. For example, fibroblast growth factor and bone morphogenetic protein act on brain cells, brain-derived neurotrophic factor modulates immune cells, and ciliary neurotrophic factor regulates liver physiology. APP is a large (695–770 amino acid) single-pass membrane protein that was initially studied in the brain because it is the source of the 40–42 amino acid amyloid β-peptide, the major pathogenic component of plaques in the brains of patients with Alzheimer’s disease. However, an enzymatic cleavage of APP at the cell surface releases a large secreted form of APP (sAPP). Although many different biological effects of sAPP have been documented, no receptors that transduce cellular responses to it have been identified. Santiago-Garci et al. 1 now provide strong evidence that sAPP selectively binds to the class A scavenger receptor (SR-A) and thereby competes with low-density lipoprotein (LDL) for cellular uptake. Because SR-A-mediated uptake of LDL by macrophages is thought to be an important event in the formation of atherosclerotic plaques in blood vessels, sAPP might play a role in suppressing the process of atherosclerosis. In addition to binding SR-A, forms of sAPP that contain a Kunitz protease inhibitor domain can also bind the LDL-related receptor (LRP). Thus, sAPP is emerging as an important player in lipoprotein metabolism, a process